Latest News & Features
Europe
Experts from Johnson & Johnson and Novartis took the stage at INTA to share the pitfalls lurking inside mergers, acquisitions and spin-offs and what in-house counsel can do about them. 7 May 2026
Americas
A California judge has denied Corcept’s bid to dismiss the lawsuit over its drug for a rare hormonal disorder, allowing the litigation to proceed on all core counts. 7 May 2026
Europe
Panellists at INTA share how workplaces can bridge generational divides and why those differences may be a team’s biggest strengths. 6 May 2026
Careers
The new partner, a former entrepreneur and self-proclaimed ‘hardcore programmer’, brings patent litigation savvy to the firm. 6 May 2026
Americas
J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices. 5 May 2026
Europe
John Ward, vice president and associate general counsel of trademarks at Moderna, chats with Tom Phillips at INTA 2026. 5 May 2026
Americas
LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection. 4 May 2026
Americas
The Office of the US Trade Representative has placed the EU on its Watch List, outlining concerns about pharma legislation, GIs and digital copyright. 1 May 2026
Careers
The IP expert will use his new role to support clients in cross-border challenges driven by innovation, digitalisation, market pressure and regulatory change. 1 May 2026
Americas
The Supreme Court's first look at the skinny label dispute dug into key questions, from the role of the skinny label to who Hikma’s statements were really meant for, in one of the most important patent cases in years. 30 April 2026